You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新諾威(300765.SZ):收購石藥聖雪100%股權事項獲深交所審核通過

格隆匯9月1日丨新諾威(300765.SZ)公佈,公司於2022年9月1日收到深交所上市審核中心出具的《創業板併購重組委2022年第2次審議會議結果公吿》,深交所上市審核中心對公司提交的擬以發行股份方式購買石藥集團恩必普藥業有限公司持有的石藥集團聖雪葡萄糖有限責任公司100%股權並募集配套資金事項進行了審議,審議結果為:同意發行股份購買資產。

同時,併購重組委會議提出問詢的主要問題:請上市公司結合阿卡波糖原料的市場前景和下游客户需求、業務壁壘、行業已有和在建產能、集採製度對產品價格影響等,説明標的資產阿卡波糖原料業務業績增長的可持續性,募投項目新增產能是否存在無法消化的風險以及應對措施,相關風險的信息披露是否充分。請獨立財務顧問發表明確意見。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account